Literature DB >> 31950162

Analogous survival for patients with glioblastoma diagnosed by either histopathological or molecular features.

Patrick J Cimino1.   

Abstract

Entities:  

Keywords:  astrocytoma; biomarkers; glioblastoma; grading

Mesh：

Substances：

Year:  2020        PMID： 31950162      PMCID： PMC7158640          DOI： 10.1093/neuonc/noaa009

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.

Authors:  David N Louis; Ken Aldape; Daniel J Brat; David Capper; David W Ellison; Cynthia Hawkins; Werner Paulus; Arie Perry; Guido Reifenberger; Dominique Figarella-Branger; Pieter Wesseling; Tracy T Batchelor; J Gregory Cairncross; Stefan M Pfister; Stefan Rutkowski; Michael Weller; Wolfgang Wick; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2017-01       Impact factor: 17.088

2.  Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.

Authors:  Maarten M J Wijnenga; Hendrikus J Dubbink; Pim J French; Nathalie E Synhaeve; Winand N M Dinjens; Peggy N Atmodimedjo; Johan M Kros; Clemens M F Dirven; Arnaud J P E Vincent; Martin J van den Bent
Journal:  Acta Neuropathol       Date:  2017-10-19       Impact factor: 17.088

3.  Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.

Authors:  C Mircea S Tesileanu; Linda Dirven; Maarten M J Wijnenga; Johan A F Koekkoek; Arnaud J P E Vincent; Hendrikus J Dubbink; Peggy N Atmodimedjo; Johan M Kros; Sjoerd G van Duinen; Marion Smits; Martin J B Taphoorn; Pim J French; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

4.  Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.

Authors:  Tejus A Bale; Justin T Jordan; Otto Rapalino; Nisha Ramamurthy; Nicholas Jessop; John C DeWitt; Valentina Nardi; Maria Martinez-Lage Alvarez; Matthew Frosch; Tracy T Batchelor; David N Louis; A John Iafrate; Daniel P Cahill; Jochen K Lennerz
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

5.  Copy number profiling across glioblastoma populations has implications for clinical trial design.

Authors:  Patrick J Cimino; Lisa McFerrin; Hans-Georg Wirsching; Sonali Arora; Hamid Bolouri; Raul Rabadan; Michael Weller; Eric C Holland
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

6.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088

7.  Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.

Authors:  Damian Stichel; Azadeh Ebrahimi; David Reuss; Daniel Schrimpf; Takahiro Ono; Mitsuaki Shirahata; Guido Reifenberger; Michael Weller; Daniel Hänggi; Wolfgang Wick; Christel Herold-Mende; Manfred Westphal; Sebastian Brandner; Stefan M Pfister; David Capper; Felix Sahm; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-09-05       Impact factor: 17.088

8.  Adult IDH wild-type lower-grade gliomas should be further stratified.

Authors:  Abudumijit Aibaidula; Aden Ka-Yin Chan; Zhifeng Shi; Yanxi Li; Ruiqi Zhang; Rui Yang; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Yu Yao; Liangfu Zhou; Jinsong Wu; Hong Chen; Ho-Keung Ng
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

9.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

Authors:  Jeanette E Eckel-Passow; Daniel H Lachance; Annette M Molinaro; Kyle M Walsh; Paul A Decker; Hugues Sicotte; Melike Pekmezci; Terri Rice; Matt L Kosel; Ivan V Smirnov; Gobinda Sarkar; Alissa A Caron; Thomas M Kollmeyer; Corinne E Praska; Anisha R Chada; Chandralekha Halder; Helen M Hansen; Lucie S McCoy; Paige M Bracci; Roxanne Marshall; Shichun Zheng; Gerald F Reis; Alexander R Pico; Brian P O'Neill; Jan C Buckner; Caterina Giannini; Jason T Huse; Arie Perry; Tarik Tihan; Mitchell S Berger; Susan M Chang; Michael D Prados; Joseph Wiemels; John K Wiencke; Margaret R Wrensch; Robert B Jenkins
Journal:  N Engl J Med       Date:  2015-06-10       Impact factor: 176.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.